Restorgenex

Developing mTOR pathway inhibitor for age-related macular degeneration & glioblastoma

placeCharlottesville, Virginia, United States calendar_todayFounded 2010 language restorgenex.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 4 times.

YearFilings
20151

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon